New hope for tough blood cancers: experimental drug APG-3288 enters human testing
Disease control
Not yet recruiting
This early-stage study tests a new oral drug, APG-3288, in about 180 adults with blood cancers like leukemia or lymphoma that returned or didn't respond to prior treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs th…
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 17, 2026 04:01 UTC